BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cytognos, S.L. - ECPv4.9.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cytognos, S.L.
X-ORIGINAL-URL:https://www.cytognos.com
X-WR-CALDESC:Events for Cytognos, S.L.
BEGIN:VTIMEZONE
TZID:"Europe/Paris"
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID="Europe/Paris":20210706T090000
DTEND;TZID="Europe/Paris":20210706T100000
DTSTAMP:20260425T203622
CREATED:20210601T083833Z
LAST-MODIFIED:20220110T075341Z
UID:18407-1625562000-1625565600@www.cytognos.com
SUMMARY:Webinar - T-cell immunotherapy evaluation - 5 PM AEST
DESCRIPTION:Join us for this webinar co-hosted by Biospecifix\, our partner in Australia\, New Zealand and Hong Kong\, to learn about a new approach to evaluate the different subsets of T cells: CD4+ and CD8+ cell subsets and differentiation. \nWhat will you learn? \nIn this webinar we present a new 7-colour panel for the identification of different subpopulations of naïve and memory T-cells\, T cell subsets tube\, where the FITC channel is free to include specific protein or markers. Taking full advantage of this panel you could monitor oncologic patients as well as measure the response to vaccines or infections. In addition\, in a similar manner\, the free FITC channel could be used to evaluate immunotherapies (e.g. for the separation of CAR T cells from the endogenous T cells). \n9 AM GMT+2 (Madrid\, Spain)\n9 AM GMT+2 (Amsterdam\, Netherlands)\n3 PM GMT+8 (Beijing\, China)\n3 PM GMT+8 (Hong Kong\, Hong Kong)\n3 PM GMT+8 (Perth\, Australia)\n4.30 PM GMT+9.3 (Adelaide\, Australia)\n5 PM GMT+10 (Sydney\, Australia)\n7 PM GMT+12 (Wellington\, New Zealand)\n4 AM GMT-3 (Rio de Janeiro\, Brasil)\n3 AM GMT-4 (New York\, NY\, USA)\n0 AM GMT-7 (Los Angeles\, CA\, USA)\n8 AM \n.fusion-button.button-1 .fusion-button-text\, .fusion-button.button-1 i {color:#bb0000;}.fusion-button.button-1 {border-width:1px;border-color:#bb0000;}.fusion-button.button-1 .fusion-button-icon-divider{border-color:#bb0000;}.fusion-button.button-1:hover .fusion-button-text\, .fusion-button.button-1:hover i\,.fusion-button.button-1:focus .fusion-button-text\, .fusion-button.button-1:focus i\,.fusion-button.button-1:active .fusion-button-text\, .fusion-button.button-1:active{color:#bb0000;}.fusion-button.button-1:hover\, .fusion-button.button-1:focus\, .fusion-button.button-1:active{border-width:1px;border-color:#bb0000;}.fusion-button.button-1:hover .fusion-button-icon-divider\, .fusion-button.button-1:hover .fusion-button-icon-divider\, .fusion-button.button-1:active .fusion-button-icon-divider{border-color:#bb0000;}.fusion-button.button-1 .fusion-button-text {text-transform:uppercase;}.fusion-button.button-1{width:auto;}Check your local time\n\n
URL:https://www.cytognos.com/event/webinar-t-cell-immunotherapy-evaluation-5-pm-aest/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/png:https://www.cytognos.com/wp-content/uploads/t-cell-biospecifix-min.png
END:VEVENT
END:VCALENDAR